Results 81 to 90 of about 88,868 (230)

Parental Consent to a Neonatal Clinical Study: The Roles of Uncertainty, Burden of Sample Collection and Societal Expectations

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Recruiting participants for neonatal clinical studies may be challenging because parental consent is required shortly after birth. This study aimed to explore reasons for parental decline of participation in a neonatal study. Method This qualitative sub‐study was conducted in the Capital Region of Denmark between June 2022 and April 2023 ...
Susanne Soendergaard Kappel   +5 more
wiley   +1 more source

Antimicrobial prescribing guidelines for horses in Australia

open access: yesAustralian Veterinary Journal, EarlyView.
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt   +18 more
wiley   +1 more source

Viability of Successful Vaginal Delivery in Triplet Pregnancies: A Retrospective Cohort Study Over 20 Years

open access: yesBirth, EarlyView.
*Adjusted for gestational age at delivery. aOR, adjusted odds ratio; CD, cesarean delivery; IRDS, infant respiratory distress syndrome; IVH, interventricular hemorrhage; OR, odds ratio; ROP, retinopathy of prematurity; VD, vaginal delivery. ABSTRACT Background Triplet pregnancies are increasingly leaning toward planned cesarean deliveries (CD), yet ...
Petra M. van Baar   +5 more
wiley   +1 more source

Acute necrotizing enterocolitis of preterm piglets is characterized by dysbiosis of ileal mucosa-associated bacteria [PDF]

open access: bronze, 2011
M. Andrea Azcárate-Peril   +7 more
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

Sildenafil for the treatment of necrotizing enterocolitis: an experimental study [PDF]

open access: gold, 2022
Sevcan İpek   +7 more
openalex   +1 more source

GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab

open access: yesCancer Science, EarlyView.
This study highlights the importance of germline genetic markers in predicting severe trAEs caused by nivolumab. Our findings support their potential to guide personalized immunotherapy and improve treatment safety and efficacy in advanced ccRCC and other cancers.
Tokiyoshi Tanegashima   +26 more
wiley   +1 more source

Review of Retinopathy of Prematurity Management in the Anti‐VEGF Era: Evolving Global Paradigms, Persistent Challenges and Our AI‐Assisted Future

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Retinopathy of prematurity (ROP) remains a major cause of preventable blindness in premature infants worldwide, with increasing incidence due to advancements in neonatal care. Management of ROP has been revolutionised by anti‐vascular endothelial growth factor (anti‐VEGF) treatments.
Kyle V. Marra   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy